Literature DB >> 20373760

Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.

Jonathan Collins1, Uwe Rinner, Michael Moser, Tomas Hudlicky, Ion Ghiviriga, Anntherese E Romero, Alexander Kornienko, Dennis Ma, Carly Griffin, Siyaram Pandey.   

Abstract

An efficient synthesis of C-1 derivatives of 7-deoxypancratistatin is reported. The key steps include the following: selective opening of an epoxide with aluminum acetylide in the presence of an aziridine; solid-state silica-gel-catalyzed opening of an aziridine; and oxidative cleavage of a phenanthrene core and its recyclization to phenanthridone to provide the key C-1 aldehyde 22. The conversion of this aldehyde to C-1 acetoxymethyl and C-1 hydroxymethyl derivatives is described along with the evaluation of their biological activity against several cancer cell lines and in an apoptosis study. The C-1 acetoxymethyl derivative has shown promising activity comparable to that of the natural product. In addition, a total synthesis of trans-dihydrolycoricidine and a formal total synthesis of 7-deoxypancratistatin are reported from aldehyde 22. Detailed experimental and spectral data are provided for all new compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373760      PMCID: PMC2872072          DOI: 10.1021/jo1003136

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  34 in total

1.  Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives.

Authors:  Tomas Hudlicky; Uwe Rinner; David Gonzalez; Hulya Akgun; Stefan Schilling; Peter Siengalewicz; Theodore A Martinot; George R Pettit
Journal:  J Org Chem       Date:  2002-12-13       Impact factor: 4.354

2.  Synthesis and biological activity of some structural modifications of pancratistatin.

Authors:  Uwe Rinner; Heather L Hillebrenner; David R Adams; Tomas Hudlicky; George R Pettit
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

3.  Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.

Authors:  G R Pettit; B Orr; S Ducki
Journal:  Anticancer Drug Des       Date:  2000-12

4.  Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a).

Authors:  G R Pettit; N Melody; D L Herald
Journal:  J Org Chem       Date:  2001-04-20       Impact factor: 4.354

5.  Total synthesis of (+)-7-deoxypancratistatin from furan.

Authors:  J L Aceña; O Arjona; M L León; J Plumet
Journal:  Org Lett       Date:  2000-11-16       Impact factor: 6.005

6.  Synthesis of some members of the hydroxylated phenanthridone subclass of the Amaryllidaceae alkaloid family.

Authors:  Albert Padwa; Hongjun Zhang
Journal:  J Org Chem       Date:  2007-03-06       Impact factor: 4.354

7.  Total synthesis of epi-7-deoxypancratistatin via aza-Payne rearrangement and intramolecular cyclization.

Authors:  Uwe Rinner; Peter Siengalewicz; Tomas Hudlicky
Journal:  Org Lett       Date:  2002-01-10       Impact factor: 6.005

8.  Antineoplastic agents 500. Narcistatin.

Authors:  George R Pettit; Noeleen Melody; Michael Simpson; Michael Thompson; Delbert L Herald; John C Knight
Journal:  J Nat Prod       Date:  2003-01       Impact factor: 4.050

9.  A short synthesis of (+)-narciclasine via a strategy derived from stereocontrolled epoxide formation and SnCl(4)-catalyzed arene-epoxide coupling.

Authors:  Shanmugham Elango; Tu-Hsin Yan
Journal:  J Org Chem       Date:  2002-10-04       Impact factor: 4.354

10.  Antineoplastic agents. 511. Direct phosphorylation of phenpanstatin and pancratistatin.

Authors:  George R Pettit; Noeleen Melody; Delbert L Herald
Journal:  J Nat Prod       Date:  2004-03       Impact factor: 4.050

View more
  15 in total

1.  A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.

Authors:  Dennis Ma; Phillip Tremblay; Kevinjeet Mahngar; Pardis Akbari-Asl; Jonathan Collins; Tomas Hudlicky; James McNulty; Siyaram Pandey
Journal:  Invest New Drugs       Date:  2011-04-15       Impact factor: 3.850

2.  Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

3.  Unnatural C-1 homologues of pancratistatin - Synthesis and promising biological activities.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko; Dennis Ma; Ian Tuffley; Siyaram Pandey
Journal:  Can J Chem       Date:  2012-09-19       Impact factor: 1.118

4.  Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells.

Authors:  Giovanni Luchetti; Robert Johnston; Véronique Mathieu; Florence Lefranc; Kathryn Hayden; Anna Andolfi; Delphine Lamoral-Theys; Mary R Reisenauer; Cody Champion; Stephen C Pelly; Willem A L van Otterlo; Igor V Magedov; Robert Kiss; Antonio Evidente; Snezna Rogelj; Alexander Kornienko
Journal:  ChemMedChem       Date:  2012-03-02       Impact factor: 3.466

5.  Enhancement of apoptotic and autophagic induction by a novel synthetic C-1 analogue of 7-deoxypancratistatin in human breast adenocarcinoma and neuroblastoma cells with tamoxifen.

Authors:  Dennis Ma; Jonathan Collins; Tomas Hudlicky; Siyaram Pandey
Journal:  J Vis Exp       Date:  2012-05-30       Impact factor: 1.355

6.  A boron-based synthesis of the natural product (+)-trans-dihydrolycoricidine.

Authors:  Sarah L Poe; James P Morken
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-31       Impact factor: 15.336

7.  Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.

Authors:  Sergey Vshyvenko; Mary Rose Reisenauer; Snezna Rogelj; Tomas Hudlicky
Journal:  Bioorg Med Chem Lett       Date:  2014-07-19       Impact factor: 2.823

8.  5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Authors:  Sean Henry; Ria Kidner; Mary R Reisenauer; Igor V Magedov; Robert Kiss; Véronique Mathieu; Florence Lefranc; Ramesh Dasari; Antonio Evidente; Xiaojie Yu; Xiuye Ma; Alexander Pertsemlidis; Regina Cencic; Jerry Pelletier; David A Cavazos; Andrew J Brenner; Alexander V Aksenov; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  Eur J Med Chem       Date:  2016-05-06       Impact factor: 6.514

9.  Systematic investigations on the reduction of 4-aryl-4-oxoesters to 1-aryl-1,4-butanediols with methanolic sodium borohydride.

Authors:  Subrata Kumar Chaudhuri; Manabendra Saha; Amit Saha; Sanjay Bhar
Journal:  Beilstein J Org Chem       Date:  2010-09-02       Impact factor: 2.883

10.  Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcumin.

Authors:  Dennis Ma; Phillip Tremblay; Kevinjeet Mahngar; Jonathan Collins; Tomas Hudlicky; Siyaram Pandey
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.